Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide

E-ISSN： 1873-4286|9|21|1665-1678

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.21, 2003-08, pp. : 1665-1678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Pharmacological Strategies in Chronic Heart Failure

By Rma van de AA Voors HWM Plokker WH van DJ van

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 6, 2004-11 ,pp. : 491-501

Springer Publishing Company

Access to resources Recommend Favorite

-Blockers in Heart Failure: The New Wave of Clinical Trials

By Krum H.

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 203-210

Adis International

Access to resources Recommend Favorite

New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia

By Cruz Constança S Cruz Luzia S Domingues Gustavo S Marcílio de Souza Carlos A

Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. : 677-688

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic strategies under development to halt the progression of renal failure

By Cernaro Valeria Trifirò Gianluca Lorenzano Giuseppina Lucisano Silvia Buemi Michele Santoro Domenico

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 693-709

Informa Healthcare

Access to resources Recommend Favorite

Heart Failure in Hypertension: Prevention and Treatment

By Georgiopoulou Vasiliki V. Kalogeropoulos Andreas P. Butler Javed

Drugs, Vol. 72, Iss. 10, 2012-07 ,pp. : 1373-1398

Adis International

Access to resources Recommend Favorite